Cargando…
Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives
In recent years, cancer immunotherapy has made remarkable achievements. Immune checkpoint inhibitors (ICIs) have been used successfully in several types of cancer in the past decade. However, expanded indication and increased use of Immune checkpoint inhibitors have resulted in increased reports of...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868416/ https://www.ncbi.nlm.nih.gov/pubmed/36699050 http://dx.doi.org/10.3389/fphar.2022.1077468 |